Loading...
Efficacy and safety of entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC)
Doebele, R Ahn, M Siena, S Drilon, A Krebs, Matthew G Lin, C De, Braud, F John, T Tan, D Seto, T
Doebele, R
Ahn, M
Siena, S
Drilon, A
Krebs, Matthew G
Lin, C
De, Braud, F
John, T
Tan, D
Seto, T
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2018
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Doebele R, Ahn M, Siena S, Drilon A, Krebs M, Lin C, et al. OA02.01Efficacy and safety of entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC). J Thorac Oncol. 2018 Oct;13(10):S321-S322.